Demand Forecast
Drill-down by category, sub-category, or SKU (p50 + p95 model)
SKU · AC0FA8802120320004
VITAMINE D3 et K2 (MK7)- 365 comprimés - 4000UI Extra Fort - Made in UK
hero
3P
COMPLEMENTS ALIMENTAIRES - THE INFUSION
Last 4 weeks demand
21
▼ 52.3% vs prev 4w
Offer Stock
6
Σ Stock across 1 live offer (1P + 3P) · 2026-10-02
1P stock
0
no 1P (MARJANEMALL) stock in the 2026-10-02 snapshot
Unit price
MAD 212
avg of last 30 sells · latest 2026-09-28
AC0FA8802120320004
History (last 52 weeks) and LightGBM p95-quantile forecast for the SKU.
Cutoff: 2026-09-28 · Total forecast: 388 units.
Actual
Realistic forecast (p50)
Optimistic
Out of stock
Price history
Weekly qty-weighted average (MAD) of every non-null price/cost column in the OrderBook for this SKU. Click a legend entry to hide/show a line.
Why this forecast?
VITAMINE D3 et K2 (MK7)- 365 comprimés - 4000UI Extra Fort - Made in UK · in the hero cohort · last 4 weeks 21 units, trending down -52.3% · on-hand 10 units
Signals the model saw
- Cohort: hero (231 days of history, — units sold over 52 weeks)
- Volatility (CV): 0.64 — moderate
- Recent trend: last 4w = 21 units · prev 4w = 44 units
- Stockouts (last 13 weeks): none — history is reliable
- Calendar events firing in forecast window: none
Model output
| Realistic forecast — next week | 2.2 units |
| Realistic forecast — next 4 weeks | 13.2 units |
| Realistic forecast — next 3 months | 121.1 units |
| Planning level (p75) — next 4 weeks the order-sizing basis; demand exceeds it ~1 week in 4 | 27.6 units |
| Optimistic — next week | 14.7 units |
| Optimistic — next 4 weeks (reorder target) | 94.8 units |
| Optimistic — next 3 months (quarterly PO target) | 387.6 units |
| Legacy μ/wk (reorder pipeline) | 8.1 |
| Revenue exposure — optimistic, 3 months | MAD 82.2K |